According to results from a recent phase II study, most patients with drug-resistant, true #extramedullary #myeloma responded to dual treatment with #talquetamab plus #teclistamab, with researchers observing a 61% PFS and 74% OS at 12 months: https://ow.ly/q6gI50YpblV #MMsm
#HemeSky #MedSky
🧬Today’s question focuses on the biological basis of adverse effects seen with talquetamab therapy.
See the answer and explanation on the next slide!
#MultipleMyeloma #MedEd #Hematology #Talquetamab #BispecificAntibodies #ClinicalTrials #HemeOnc #Immunotherapy #HEMEHUB
🩸 Today’s question focuses on combination therapy evaluated in the MajesTEC-3 trial for relapsed/refractory multiple myeloma (RRMM).
See the answer and explanation on the next slide!
#MultipleMyeloma #Teclistamab #Pomalidomide #Daratumumab #Elranatamab #Carfilzomib #Talquetamab #Hematology
🩸 More insights on clinical efficacy and survival outcomes in Multiple Myeloma
#MultipleMyeloma #HemeOnc #Hematology #BispecificAntibodies #Linvoseltamab #Teclistamab #Talquetamab #ClinicalTrials #HEMEHUB #MedEd
Bridging therapy with #talquetamab enabled patients with high-risk #myeloma #MMsm to successfully transition to #BCMA #CARTcell therapy, with 88% experiencing rapid disease control and proceeding to treatment with ide-cel or cilta-cel: ow.ly/7JkM50X8KYa
#HemeSky #MyelomaSky #MultipleMyeloma
Excellent article sur le pontage du #Talquetamab 💊 vers les cellules #CAR_T 🧬 dans le #MyélomeMultiple 🩸 R/R
Le pontage du talquetamab ( #AnticorpsBispécifique 💊) est faisable, sûr et efficace, permettant un contrôle rapide de la maladie avec une toxicité minimale.
#MultipleMyeloma #CAR_T #Talquetamab #RRMM #Oncology #Hematology #CellTherapy #RealWorldEvidence #MyelomaResearch #Immunotherapy #GPRC5D #BCMA
📢 Des nouvelles de l’ #EHA2025 à #Milan !
Développements dans le #MyélomeMultiple 🩸:
🔹 Progrès dans les thérapies #BCMA (ex, #Talquetamab, #CAR_T)
🔹 De l'opportunité avec l’ #Isatuximab + #CRD
🔹 Une réponse plus profonde grâce à des stratégies modernes de 1ère ligne
myelom.online/multiples-my...
Mieloma multiplo: disponibile in Italia farmaco con nuovo bersaglio terapeutico #MielomaMultiplo #Talquetamab #Immunoterapia
Evanica Rosselli shared management strategies for #talquetamab skin and oral toxicities during Poster Session 3 at #ONS50.
View her abstract: ons.confex.com/ons/2025/meeti…
